Repligen Corp SEC filings RGEN
Repligen Corp has 1,003 filings in SEC EDGAR's recent list, going back to May 13, 2010. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 4, 2026 | — |
| S-4/A | Filing | Sep 4, 2026 | — |
| S-4 | Registration for a merger or exchange | Aug 25, 2026 | — |
| 424B7 | Filing | Nov 5, 2021 | — |
| 424B5 | Prospectus supplement | Dec 8, 2020 | — |
| 424B5 | Prospectus supplement | Dec 7, 2020 | — |
| 424B5 | Prospectus supplement | Jul 17, 2019 | — |
| 424B5 | Prospectus supplement | Jul 17, 2019 | — |
| FWP | Free writing prospectus | Jul 17, 2019 | — |
| 424B5 | Prospectus supplement | Jul 15, 2019 | — |
| 424B5 | Prospectus supplement | Jul 15, 2019 | — |
| 424B5 | Prospectus supplement | May 1, 2019 | — |
| 424B5 | Prospectus supplement | Apr 29, 2019 | — |
| S-3ASR | Automatic shelf registration | Apr 29, 2019 | — |
| S-8 | Employee stock plan registration | May 16, 2018 | — |
| 424B5 | Prospectus supplement | Jun 29, 2017 | — |
| 424B5 | Prospectus supplement | Jun 26, 2017 | — |
| 424B5 | Prospectus supplement | May 20, 2016 | — |
| FWP | Free writing prospectus | May 19, 2016 | — |
| 424B5 | Prospectus supplement | May 18, 2016 | — |
| S-3ASR | Automatic shelf registration | May 18, 2016 | — |
| S-3ASR | Automatic shelf registration | Apr 15, 2016 | — |
| S-8 | Employee stock plan registration | Jun 2, 2014 | — |
| S-8 | Employee stock plan registration | Nov 8, 2012 | — |
| S-8 | Employee stock plan registration | May 24, 2012 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 730272
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.